MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$19,830K
Free Cash flow
$215,670K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income
Additional borrowings
Depreciation & amortization
Others
Negative Cash Flow Breakdown
Repurchase of common shares
Property and equipment additions
Repayments of long-term debt
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
364,590
358,678
447,837
379,105
Depreciation & amortization
167,338
155,426
163,334
155,060
Stock-based compensation expense
22,909
22,504
25,102
24,879
Unrealized gain on non-marketable securities
-
-
93,291
-
(gain) loss on sales of assets and businesses
532
5,046
-5,135
0
Costs related to extinguishment of debt
-
-
0
-
Accounts receivable
14,045
123,862
23,775
201,574
Accrued interest
11,021
-10,992
11,105
-11,584
Accrued and deferred income taxes
75,013
-104,772
-17,846
-16,626
Other working capital accounts
59,235
122,911
-78,774
4,909
Other assets and deferred charges
6,209
12,257
-1,030
7,225
Other, net
10,974
-221
586
2,971
Accrued insurance expense, net of commercial premiums paid
94,867
62,568
59,717
82,358
Payments made in settlement of self-insurance claims, net of commercial insurance reimbursements
51,320
49,015
96,497
78,197
Deferred grant revenue
-
-
0
-
Net cash provided by operating activities
443,303
401,628
574,693
380,678
Property and equipment additions
227,633
217,157
281,220
228,892
Proceeds received from sales of assets and businesses
1,428
14,304
12,883
0
Acquisition of businesses and property
0
4,857
32
39,458
Inflows (outflows) from foreign exchange contracts that hedge our net u.k. investment
2,705
-14,716
2,862
-17,051
Costs incurred for purchase and development of enterprise resource planning application
5,351
4,613
6,019
18,676
Proceeds received from sale of marketable equity securities
-
-
63,073
-
Investments in non-marketable securities
-
-
9,831
-
Decrease (increase) in capital reserves of commercial insurance subsidiary
-28
-28
-42
-562
Net cash used in investing activities
-234,233
-197,579
-223,966
-269,413
Repayments of long-term debt
157,014
44,731
15,713
9,243
Additional borrowings
300,000
40
76,550
114,385
Financing costs
1,410
-
0
382
Repurchase of common shares
320,752
163,849
352,010
237,399
Dividends paid
11,786
12,974
12,365
12,468
Issuance of common stock
4,877
3,782
4,610
3,982
Profit distributions to noncontrolling interests
3,977
7,912
1,325
788
Purchase of ownership interests by minority members, net
574
3,750
4,118
7,392
Net cash used in financing activities
-189,488
-221,894
-296,135
-134,521
Effect of exchange rate changes on cash and cash equivalents
248
-924
127
-1,541
Increase in cash, cash equivalents and restricted cash
19,830
-18,769
54,719
-24,797
Cash, cash equivalents and restricted cash, beginning of period
252,553
271,322
223,726
223,726
Cash, cash equivalents and restricted cash, end of period
272,383
252,553
271,322
216,603
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$364,590K
(0.55%↑ Y/Y)
Depreciation & amortization
$167,338K
(10.09%↑ Y/Y)
Accrued insurance
expense, net of...
$94,867K
(100.30%↑ Y/Y)
Stock-based compensation
expense
$22,909K
(-4.99%↓ Y/Y)
Other, net
$10,974K
(-11.01%↓ Y/Y)
Net cash provided by
operating activities
$443,303K
(-19.25%↓ Y/Y)
Effect of exchange rate
changes on cash and cash...
$248K
(-89.15%↓ Y/Y)
Canceled cashflow
$217,375K
Increase in cash, cash
equivalents and restricted...
$19,830K
(12.20%↑ Y/Y)
Canceled cashflow
$423,721K
Accrued and deferred
income taxes
$75,013K
(-48.11%↓ Y/Y)
Other working capital
accounts
$59,235K
(186.92%↑ Y/Y)
Payments made in
settlement of...
$51,320K
(-39.47%↓ Y/Y)
Accounts receivable
$14,045K
(111.17%↑ Y/Y)
Accrued interest
$11,021K
(-29.43%↓ Y/Y)
Other assets and
deferred charges
$6,209K
(-71.67%↓ Y/Y)
(gain) loss on sales of
assets and businesses
$532K
(118.78%↑ Y/Y)
Proceeds received from
sales of assets and...
$1,428K
(-52.08%↓ Y/Y)
Decrease (increase) in
capital reserves of...
-$28K
(-114.14%↓ Y/Y)
Additional borrowings
$300,000K
(618.56%↑ Y/Y)
Issuance of common stock
$4,877K
(8.89%↑ Y/Y)
Purchase of ownership
interests by minority...
$574K
(-91.71%↓ Y/Y)
Net cash used in
investing activities
-$234,233K
(23.44%↑ Y/Y)
Net cash used in
financing activities
-$189,488K
(16.76%↑ Y/Y)
Canceled cashflow
$1,456K
Canceled cashflow
$305,451K
Property and equipment
additions
$227,633K
(-14.43%↓ Y/Y)
Costs incurred for
purchase and development...
$5,351K
Inflows (outflows) from
foreign exchange...
$2,705K
(-93.67%↓ Y/Y)
Repurchase of common shares
$320,752K
(106.73%↑ Y/Y)
Repayments of long-term
debt
$157,014K
(1564.17%↑ Y/Y)
Dividends paid
$11,786K
(-8.64%↓ Y/Y)
Profit distributions
to noncontrolling...
$3,977K
(7.23%↑ Y/Y)
Financing costs
$1,410K
Buy us a coffee
UHS_logo-svg
UNIVERSAL HEALTH SERVICES INC (UHS)
UHS_logo-svg
UNIVERSAL HEALTH SERVICES INC (UHS)